Polycystic Ovary Syndrome Awareness Month 2020

September is Polycystic Ovary Syndrome Awareness Month 

Polycystic ovary syndrome (PCOS) is a common condition affecting 8% to 13% of women. Being overweight worsens all clinical features of PCOS. These clinical features include reproductive issues such as reduced frequency of ovulation and irregular menstrual cycles, reduced fertility, polycystic ovaries on ultrasound and high levels of male hormones such as testosterone, which can cause unwanted facial or body hair growth and acne. PCOS is also associated with metabolic features, with risk factors for diabetes and cardiovascular disease including high levels of insulin or insulin resistance and abnormal cholesterol levels. PCOS affects quality of life and can worsen anxiety and depression either due to its symptoms or due to the diagnosis of a chronic disease.

Cochrane Gynaecology and Fertility Group (CGF) has published 19 systematic reviews on the effectiveness and safety of various interventions for the treatment and management of PCOS.

Here is the curated list of our PCOS related Cochrane systematic reviews: